Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Farzan: Preventing HIV-1 transmission with a novel entry inhibitor, eCD4-Ig |
| Strategy: | Prophylactic neutralizing Ab |
| Study Type: | Antibody Screening |
| Species: | Non-Organism Study |
| Stage: | Assays Completed |
| Study Start Date: | 2015-09-30 |
| Study Made Public: | 2016-12-16 |
Title
Neutralization of eCD4-Ig variants 1v34 and 2v26
Description
CAVD 521 is a monoclonal antibody screening study evaluating the neutralization of IC50s and IC80s using a panel of 200 Clade C isolates (Early/Acute Pseudovirus Panel) for two eCD4-Ig variants.
Sign in to see full information about this study and to download study data.
Products
No Products used in studyIntegrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.